Association of risk factors for cardiovascular disease and glomerular filtration rate: A community-based study of 4925 adults in Beijing

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 3924-3931

  Wang, Fan ^a   Ye, Ping ^a   Luo, Leiming ^a   Xiao, Wenkai ^a   Wu, Hongmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

cardiovascular disease risk factors; chronic kidney disease; cross sectional study; glomerular filtration rate

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHINA; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMMUNITY CARE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HEALTH SURVEY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INDEPENDENT VARIABLE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; CHINA; CHRONIC DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 78649496733     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq327     Document Type: Article

References (43)

1. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007; 18: 2644-2648
2. Best PJM, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119
3. Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a Predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636
4. Kagiyama S, Matsumura K, Ansai T et al. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan. Hypertens Res 2008; 31: 2053-2058
5. Manjunath G, Tighiouart H, Ibrahim H et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41: 47-55 (Pubitemid 36044403)
6. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
7. Smith PM, Burgess E. Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. CMAJ 2009; 180: 1297-1303
8. Hu J, Wallace DC, Jones E et al. Cardiometabolic health of Chinese older adults with diabetes living in Beijing, China. Public Health Nurs 2009; 26: 500-511
9. Shankar A, Leng CL, Chia KS et al. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant 2008; 23: 1910-1918
10. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252
11. Zhang LX, Zuo L, Xu GB et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 2007; 22: 1093-1099
12. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944
13. Levin A, Rocco M. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49: S1-S179
14. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266
15. Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diab Care 2003; 26: 3160-3167
16. The Association Committee of Prevention and Treatment of Dys-lipidemia. The 2007 Guidelines for Prevention and Treatment of Dyslipidemia in Adults in China. Chinese Journal of Cardiology 2007; 35: 390-413
17. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-378
18. Kendrick J, Chonchol MB. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol 2008; 4: 672-681
19. Shishehbor MH, Oliveira LP, Lauer MS et al. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol 2008; 101: 1741-1746
20. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 17: 2154-2169
21. Cottone S, Lorito MC, Riccobene R et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008; 21: 175-179
22. Yoshida T, Takei T, Shirota S et al. Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population. Intern Med 2008; 47: 1859-1864
23. Josef C, Brad A, Mark JS. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens 2004; 13: 73-81
24. Shepherd J, Kastelein JJ, Bittner Vet al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Car-diol 2008; 15: 1448-1454
25. Vaziri ND, Moradi H. Mechanisms of dyslipidemia of chronic renal failure. Hemodial Int 2006; 10: 1-7
26. Kwan BC, Beddhu S, Kronenberg F et al. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis? Nat Clin Pract Nephrol 2006; 2: 76-77
27. National Kidney Foundation. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with chronic kidney disease. Am J Kidney Dis 2003; 41: S1-S91
28. Theodoros IK, Panagiotis AK. The role of statins in chronic kidney disease (CKD): friend or foe? Pharmacol Ther 2009; 122: 312-323
29. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850
30. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
31. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
32. Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487
33. Noori N, Hosseinpanah F, Nasiri AA et al. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 2009; 3: 228-237
34. Klein R, Klein BE, Moss SE et al. Ten-year incidence of gross pro-teinuria in people with diabetes. Diabetes 1995; 44: 916-923
35. Sawicki PT, Didjurgeit U, Muhlhauser I et al. Smoking is associated with progression of diabetic nephropathy. Diab Care 1994; 17: 126-131
36. Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 2003; 13: 712-720
37. Briganti EM, Branley P, Chadban SJ et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002; 40: 704-712
38. Ejerblad E, Fored CM, Lindblad P et al. Association between smoking and chronic renal failure in a nationwide population-based case- control study. J Am Soc Nephrol 2004; 15: 2178-2185
39. Lu B, Song XY, Dong X et al. High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai. J Diab Complications 2008; 22: 96-103
40. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 13: 1413-1418
41. Hillege HL, Janssen WM, Bak AA et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an inde-pendent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 6: 519-526 42.
42. Onuigbo MAC. Reno-prevention vs. reno-protection: a critical reappraisal of the evidence-base from the large RAAS blockade trials after ontarget-a call for more circumspection. Q J Med 2009; 102: 155-167
43. Casas JP, Chua W, Loukogeorgakis S et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026-2033